Skip to main content
Top
Published in: Clinical Rheumatology 12/2017

Open Access 01-12-2017 | Original Article

Prevalence of and factors associated with renal dysfunction in rheumatoid arthritis patients: a cross-sectional study in community hospitals

Authors: Shunsuke Mori, Tamami Yoshitama, Naoyuki Hirakata, Yukitaka Ueki

Published in: Clinical Rheumatology | Issue 12/2017

Login to get access

Abstract

This study was designed to determine the prevalence of renal dysfunction in rheumatoid arthritis (RA) patients and to identify factors associated with this complication. Between October 2014 and May 2015, we consecutively recruited RA patients at rheumatology sections of community hospitals in Japan. Each patient’s absolute and body surface area (BSA)-indexed estimated glomerular filtration rate (eGFR) values were measured twice over a 3-month interval. Renal dysfunction was defined as absolute eGFR or BSA-indexed eGFR < 60. Albuminuria and hematuria were also recorded. Associations between renal dysfunction and possible risk factors were examined by multivariate logistic regression analyses. A total of 1908 outpatients with RA were included in this study. The prevalence of renal dysfunction based on absolute eGFR and BSA-indexed eGFR was 33.8 and 18.6%, respectively. Albuminuria was observed in 8.1% of this patient cohort, and the prevalence of hematuria was 7.5%. Advanced age (odds ratio [OR] 7.24, p < 0.001), female sex (OR 3.12, p < 0.001), hypertension (OR 2.22, p < 0.001), and obesity (OR 0.59, p < 0.001) were independently associated with the risk of absolute eGFR-based renal dysfunction. Advanced age (OR 5.19, p < 0.001) and hypertension (OR 3.05, p < 0.001) also had associations with BSA-indexed eGFR-based renal dysfunction. RA duration, stages, severity, and cumulative steroid dose were considered significant risk factors in univariate analyses, but their associations were less potent after adjustment for other covariates. Renal dysfunction is relatively common in RA patients and is mainly associated with advanced age and hypertension but not with RA-related factors.
Literature
1.
go back to reference Sihvonen S, Korpela M, Mustonen J, Laippala P, Pasternack A (2004) Renal disease as a predictor of increased mortality among patients with rheumatoid arthritis. Nephron Clin Pract 96:c107–c114CrossRefPubMed Sihvonen S, Korpela M, Mustonen J, Laippala P, Pasternack A (2004) Renal disease as a predictor of increased mortality among patients with rheumatoid arthritis. Nephron Clin Pract 96:c107–c114CrossRefPubMed
2.
go back to reference Mori S, Yoshitama T, Hidaka T, Hirakata N, Ueki Y (2015) Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in Japan (the ACTRA-RI study). Ann Rheum Dis 74:627–630CrossRefPubMedPubMedCentral Mori S, Yoshitama T, Hidaka T, Hirakata N, Ueki Y (2015) Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in Japan (the ACTRA-RI study). Ann Rheum Dis 74:627–630CrossRefPubMedPubMedCentral
3.
go back to reference Koseki Y, Terai C, Moriguchi M, Uesato M, Kamatani N (2001) A prospective study of renal disease in patients with early rheumatoid arthritis. Ann Rheum Dis 60:327–331CrossRefPubMedPubMedCentral Koseki Y, Terai C, Moriguchi M, Uesato M, Kamatani N (2001) A prospective study of renal disease in patients with early rheumatoid arthritis. Ann Rheum Dis 60:327–331CrossRefPubMedPubMedCentral
4.
go back to reference Karie S, Gandjbakhch F, Janus N et al (2008) Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX study. Rheumatology (Oxford) 47:350–354CrossRef Karie S, Gandjbakhch F, Janus N et al (2008) Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX study. Rheumatology (Oxford) 47:350–354CrossRef
5.
go back to reference Daoussis D, Panoulas VF, Antonopoulos I et al (2010) Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis. Ann Rheum Dis 69:517–521CrossRefPubMed Daoussis D, Panoulas VF, Antonopoulos I et al (2010) Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis. Ann Rheum Dis 69:517–521CrossRefPubMed
6.
go back to reference Daoussis D, Panoulas VF, John H et al (2011) Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation. Clin Rheumatol 30:477–484CrossRefPubMed Daoussis D, Panoulas VF, John H et al (2011) Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation. Clin Rheumatol 30:477–484CrossRefPubMed
7.
go back to reference Hickson LJ, Crowson CS, Gabriel SE, McCarthy JT, Matteson EL (2014) Development of reduced kidney function in rheumatoid arthritis. Am J Kidney Dis 63:206–213CrossRefPubMed Hickson LJ, Crowson CS, Gabriel SE, McCarthy JT, Matteson EL (2014) Development of reduced kidney function in rheumatoid arthritis. Am J Kidney Dis 63:206–213CrossRefPubMed
8.
go back to reference Couderc M, Tatar Z, Pereira B et al (2016) Prevalence of renal impairment in patients with rheumatoid arthritis: results from a cross-sectional multicenter study. Arthritis Care Res (Hoboken) 68:638–644CrossRef Couderc M, Tatar Z, Pereira B et al (2016) Prevalence of renal impairment in patients with rheumatoid arthritis: results from a cross-sectional multicenter study. Arthritis Care Res (Hoboken) 68:638–644CrossRef
9.
10.
go back to reference Helin HJ, Korpela MM, Mustonen JT, Pasternack AI (1995) Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis. Arthritis Rheum 38:242–247CrossRefPubMed Helin HJ, Korpela MM, Mustonen JT, Pasternack AI (1995) Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis. Arthritis Rheum 38:242–247CrossRefPubMed
11.
go back to reference Nakano M, Ueno M, Nishi S et al (1998) Analysis of renal pathology and drug history in 158 Japanese patients with rheumatoid arthritis. Clin Nephrol 50:154–160PubMed Nakano M, Ueno M, Nishi S et al (1998) Analysis of renal pathology and drug history in 158 Japanese patients with rheumatoid arthritis. Clin Nephrol 50:154–160PubMed
12.
go back to reference Immonen K, Finne P, Gronhagen-Riska C et al (2011) A marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases—data from nationwide registries in Finland. Amyloid 18:25–28CrossRefPubMed Immonen K, Finne P, Gronhagen-Riska C et al (2011) A marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases—data from nationwide registries in Finland. Amyloid 18:25–28CrossRefPubMed
13.
go back to reference Stuveling EM, Hillege HL, Bakker SJ, Gans RO, De Jong PE, De Zeeuw D (2003) C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int 63:654–661CrossRefPubMed Stuveling EM, Hillege HL, Bakker SJ, Gans RO, De Jong PE, De Zeeuw D (2003) C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int 63:654–661CrossRefPubMed
14.
go back to reference Fried L, Solomon C, Shlipak M et al (2004) Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol 15:3184–3191CrossRefPubMed Fried L, Solomon C, Shlipak M et al (2004) Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol 15:3184–3191CrossRefPubMed
15.
go back to reference Tonelli M, Sacks F, Pfeffer M et al (2005) Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 68:237–245CrossRefPubMed Tonelli M, Sacks F, Pfeffer M et al (2005) Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 68:237–245CrossRefPubMed
16.
go back to reference Haroon M, Adeeb F, Devlin J, O Gradaigh D, Walker F (2011) A comparative study of renal dysfunction in patients with inflammatory arthropathies: strong association with cardiovascular diseases and not with anti-rheumatic therapies, inflammatory markers or duration of arthritis. Int J Rheum Dis 14:255–260CrossRefPubMed Haroon M, Adeeb F, Devlin J, O Gradaigh D, Walker F (2011) A comparative study of renal dysfunction in patients with inflammatory arthropathies: strong association with cardiovascular diseases and not with anti-rheumatic therapies, inflammatory markers or duration of arthritis. Int J Rheum Dis 14:255–260CrossRefPubMed
17.
go back to reference Chiu HY, Huang HL, Li CH et al (2015) Increased risk of chronic kidney disease in rheumatoid arthritis associated with cardiovascularcomplications—a national population-based cohort study. PLoS One 10:e0136508CrossRefPubMedPubMedCentral Chiu HY, Huang HL, Li CH et al (2015) Increased risk of chronic kidney disease in rheumatoid arthritis associated with cardiovascularcomplications—a national population-based cohort study. PLoS One 10:e0136508CrossRefPubMedPubMedCentral
18.
go back to reference Kochi M, Kohagura K, Shiohira Y, Iseki K, Ohya Y (2016) Inflammation as a risk of developing chronic kidney disease in rheumatoid arthritis. PLoS One 11:e0160225CrossRefPubMedPubMedCentral Kochi M, Kohagura K, Shiohira Y, Iseki K, Ohya Y (2016) Inflammation as a risk of developing chronic kidney disease in rheumatoid arthritis. PLoS One 11:e0160225CrossRefPubMedPubMedCentral
19.
go back to reference Nurmohamed MT, Heslinga M, Kitas GD (2015) Cardiovascular comorbidity in rheumatic diseases. Nat Rev Rheumatol 11:693–704CrossRefPubMed Nurmohamed MT, Heslinga M, Kitas GD (2015) Cardiovascular comorbidity in rheumatic diseases. Nat Rev Rheumatol 11:693–704CrossRefPubMed
20.
go back to reference Hollan I, Dessein PH, Ronda N et al (2015) Prevention of cardiovascular disease in rheumatoid arthritis. Autoimmun Rev 14:952–969CrossRefPubMed Hollan I, Dessein PH, Ronda N et al (2015) Prevention of cardiovascular disease in rheumatoid arthritis. Autoimmun Rev 14:952–969CrossRefPubMed
21.
go back to reference Solomon DH, Karlson EW, Rimm EB et al (2003) Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107:1303–1307CrossRefPubMed Solomon DH, Karlson EW, Rimm EB et al (2003) Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107:1303–1307CrossRefPubMed
23.
go back to reference Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59:1690–1697CrossRefPubMed Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59:1690–1697CrossRefPubMed
24.
go back to reference van Sijl AM, van den Oever IA, Peters MJ et al (2012) Subclinical renal dysfunction is independently associated with cardiovascular events in rheumatoid arthritis: the CARRE study. Ann Rheum Dis 71:341–344CrossRefPubMed van Sijl AM, van den Oever IA, Peters MJ et al (2012) Subclinical renal dysfunction is independently associated with cardiovascular events in rheumatoid arthritis: the CARRE study. Ann Rheum Dis 71:341–344CrossRefPubMed
25.
go back to reference Dessein PH, Hsu HC, Tsang L et al (2015) Kidney function, endothelial activation and atherosclerosis in black and white Africans with rheumatoid arthritis. PLoS One 10:e0121693CrossRefPubMedPubMedCentral Dessein PH, Hsu HC, Tsang L et al (2015) Kidney function, endothelial activation and atherosclerosis in black and white Africans with rheumatoid arthritis. PLoS One 10:e0121693CrossRefPubMedPubMedCentral
26.
go back to reference Dougados M, Simon P, Braun J et al (2011) ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis. Ann Rheum Dis 70:249–251CrossRefPubMed Dougados M, Simon P, Braun J et al (2011) ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis. Ann Rheum Dis 70:249–251CrossRefPubMed
27.
go back to reference Matsuo S, Imai E, Horio M et al (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRefPubMed Matsuo S, Imai E, Horio M et al (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRefPubMed
28.
go back to reference Delanaye P, Mariat C, Cavalier E, Krzesinski JM (2009) Errors induced by indexing glomerular filtration rate for body surface area: reductio ad absurdum. Nephrol Dial Transplant 24:3593–3596CrossRefPubMed Delanaye P, Mariat C, Cavalier E, Krzesinski JM (2009) Errors induced by indexing glomerular filtration rate for body surface area: reductio ad absurdum. Nephrol Dial Transplant 24:3593–3596CrossRefPubMed
29.
go back to reference Redal-Baigorri B, Rasmussen K, Heaf JG (2014) Indexing glomerular filtration rate to body surface area: clinical consequences. J Clin Lab Anal 28:83–90CrossRefPubMed Redal-Baigorri B, Rasmussen K, Heaf JG (2014) Indexing glomerular filtration rate to body surface area: clinical consequences. J Clin Lab Anal 28:83–90CrossRefPubMed
30.
go back to reference Redal-Baigorri B, Rasmussen K, Heaf JG (2013) The use of absolute values improves performance of estimation formulae: a retrospective cross sectional study. BMC Nephrol 14:271CrossRefPubMedPubMedCentral Redal-Baigorri B, Rasmussen K, Heaf JG (2013) The use of absolute values improves performance of estimation formulae: a retrospective cross sectional study. BMC Nephrol 14:271CrossRefPubMedPubMedCentral
31.
go back to reference Levin A, Stevens PE (2014) Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int 85:49–61CrossRefPubMed Levin A, Stevens PE (2014) Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int 85:49–61CrossRefPubMed
32.
go back to reference Saisho K, Yoshikawa N, Sugata K, Hamada H, Tohma S (2016) Prevalence of chronic kidney disease and administration of RA-related drugs in patients with RA: the NinJa 2012 study in Japan. Mod Rheumatol 26:331–335CrossRefPubMed Saisho K, Yoshikawa N, Sugata K, Hamada H, Tohma S (2016) Prevalence of chronic kidney disease and administration of RA-related drugs in patients with RA: the NinJa 2012 study in Japan. Mod Rheumatol 26:331–335CrossRefPubMed
33.
go back to reference Imai E, Horio M, Iseki K et al (2007) Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol 11:156–163CrossRefPubMed Imai E, Horio M, Iseki K et al (2007) Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol 11:156–163CrossRefPubMed
34.
go back to reference Chi CC, Wang J, Chen YF, Wang SH, Chen FL, Tung TH (2015) Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: a nationwide population-based cohort study. J Dermatol Sci 78:232–238CrossRefPubMed Chi CC, Wang J, Chen YF, Wang SH, Chen FL, Tung TH (2015) Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: a nationwide population-based cohort study. J Dermatol Sci 78:232–238CrossRefPubMed
35.
go back to reference Chiu HY, Huang HL, Li CH et al (2015) Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study. Br J Dermatol 173:146–154CrossRefPubMed Chiu HY, Huang HL, Li CH et al (2015) Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study. Br J Dermatol 173:146–154CrossRefPubMed
36.
go back to reference Domrongkitchaiporn S, Sritara P, Kitiyakara C et al (2005) Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J Am Soc Nephrol 16:791–799CrossRefPubMed Domrongkitchaiporn S, Sritara P, Kitiyakara C et al (2005) Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J Am Soc Nephrol 16:791–799CrossRefPubMed
37.
go back to reference Moller B, Pruijm M, Adler S et al (2015) Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study. Ann Rheum Dis 74:718–723CrossRefPubMed Moller B, Pruijm M, Adler S et al (2015) Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study. Ann Rheum Dis 74:718–723CrossRefPubMed
38.
go back to reference Brotman DJ, Walker E, Lauer MS, O'Brien RG (2005) In search of fewer independent risk factors. Arch Intern Med 165:138–145CrossRefPubMed Brotman DJ, Walker E, Lauer MS, O'Brien RG (2005) In search of fewer independent risk factors. Arch Intern Med 165:138–145CrossRefPubMed
Metadata
Title
Prevalence of and factors associated with renal dysfunction in rheumatoid arthritis patients: a cross-sectional study in community hospitals
Authors
Shunsuke Mori
Tamami Yoshitama
Naoyuki Hirakata
Yukitaka Ueki
Publication date
01-12-2017
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 12/2017
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3804-5

Other articles of this Issue 12/2017

Clinical Rheumatology 12/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.